Back to Search Start Over

Mapping analysis to predict the associated EuroQol five-dimension three-level utility values from the Oxford Knee Score

Authors :
Nick D. Clement
Irrum Afzal
Christian J. H. Peacock
Deborah MacDonald
Gavin J. Macpherson
James T. Patton
Vipin Asopa
David H. Sochart
Deiary F. Kader
Source :
Bone & Joint Open. 3:573-581
Publication Year :
2022
Publisher :
British Editorial Society of Bone & Joint Surgery, 2022.

Abstract

Aims The aims of this study were to assess mapping models to predict the three-level version of EuroQoL five-dimension utility index (EQ-5D-3L) from the Oxford Knee Score (OKS) and validate these before and after total knee arthroplasty (TKA). Methods A retrospective cohort of 5,857 patients was used to create the prediction models, and a second cohort of 721 patients from a different centre was used to validate the models, all of whom underwent TKA. Patient characteristics, BMI, OKS, and EQ-5D-3L were collected preoperatively and one year postoperatively. Generalized linear regression was used to formulate the prediction models. Results There were significant correlations between the OKS and EQ-5D-3L preoperatively ( r = 0.68; p < 0.001) and postoperatively ( r = 0.77; p < 0.001) and for the change in the scores ( r = 0.61; p < 0.001). Three different models (preoperative, postoperative, and change) were created. There were no significant differences between the actual and predicted mean EQ-5D-3L utilities at any timepoint or for change in the scores (p > 0.090) in the validation cohort. There was a significant correlation between the actual and predicted EQ-5D-3L utilities preoperatively ( r = 0.63; p < 0.001) and postoperatively ( r = 0.77; p < 0.001) and for the change in the scores ( r = 0.56; p < 0.001). Bland-Altman plots demonstrated that a lower utility was overestimated, and higher utility was underestimated. The individual predicted EQ-5D-3L that was within ± 0.05 and ± 0.010 (minimal clinically important difference (MCID)) of the actual EQ-5D-3L varied between 13% to 35% and 26% to 64%, respectively, according to timepoint assessed and change in the scores, but was not significantly different between the modelling and validation cohorts (p ≥ 0.148). Conclusion The OKS can be used to estimate EQ-5D-3L. Predicted individual patient utility error beyond the MCID varied from one-third to two-thirds depending on timepoint assessed, but the mean for a cohort did not differ and could be employed for this purpose. Cite this article: Bone Jt Open 2022;3(7):573–581.

Subjects

Subjects :
General Engineering

Details

ISSN :
26331462
Volume :
3
Database :
OpenAIRE
Journal :
Bone & Joint Open
Accession number :
edsair.doi.dedup.....448b53ee2ef3e9151b2a8e9846ae1a0a
Full Text :
https://doi.org/10.1302/2633-1462.37.bjo-2022-0054.r1